267 related articles for article (PubMed ID: 16051032)
1. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas.
Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF
Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles in thyroid carcinomas.
Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
Visone R; Russo L; Pallante P; De Martino I; Ferraro A; Leone V; Borbone E; Petrocca F; Alder H; Croce CM; Fusco A
Endocr Relat Cancer; 2007 Sep; 14(3):791-8. PubMed ID: 17914108
[TBL] [Abstract][Full Text] [Related]
8. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
[TBL] [Abstract][Full Text] [Related]
10. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
[TBL] [Abstract][Full Text] [Related]
11. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
[TBL] [Abstract][Full Text] [Related]
12. Gene expression and the biological phenotype of papillary thyroid carcinomas.
Delys L; Detours V; Franc B; Thomas G; Bogdanova T; Tronko M; Libert F; Dumont JE; Maenhaut C
Oncogene; 2007 Dec; 26(57):7894-903. PubMed ID: 17621275
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
[TBL] [Abstract][Full Text] [Related]
14. Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma.
Baris O; Mirebeau-Prunier D; Savagner F; Rodien P; Ballester B; Loriod B; Granjeaud S; Guyetant S; Franc B; Houlgatte R; Reynier P; Malthiery Y
Oncogene; 2005 Jun; 24(25):4155-61. PubMed ID: 15806164
[TBL] [Abstract][Full Text] [Related]
15. Extraction of high-integrity RNA suitable for microarray gene expression analysis from long-term stored human thyroid tissues.
Walter MA; Seboek D; Demougin P; Bubendorf L; Oberholzer M; Müller-Brand J; Müller B
Pathology; 2006 Jun; 38(3):249-53. PubMed ID: 16753748
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.
Mitselou A; Peschos D; Dallas P; Charalabopoulos K; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2004 Dec; 26(4):282-6. PubMed ID: 15627060
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas.
Stolf BS; Carvalho AF; Martins WK; Runza FB; Brun M; Hirata R; Jordão Neves E; Soares FA; Postigo-Dias J; Kowalski LP; Reis LF
Cancer Lett; 2003 Mar; 191(2):193-202. PubMed ID: 12618333
[TBL] [Abstract][Full Text] [Related]
18. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A
Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049
[TBL] [Abstract][Full Text] [Related]
20. Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice.
Fedele M; Palmieri D; Chiappetta G; Pasquinelli R; De Martino I; Arra C; Palma G; Valentino T; Pierantoni GM; Viglietto G; Rothstein JL; Santoro M; Fusco A
Endocr Relat Cancer; 2009 Jun; 16(2):483-90. PubMed ID: 19261681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
